Results 311 to 320 of about 4,227,388 (391)

Antiparasitic drug design

Parasitology Today, 1989
D, Hart, A, Langridge, D, Barlow, B, Sutton   +3 more
openaire   +2 more sources

A case of fatal idiosyncratic reaction to the designer drug 3,4-methylenedioxypyrovalerone (MDPV) and review of the literature

Forensic Science, Medicine, and Pathology, 2017
B. Desharnais, Yann Dazé, L. Huppertz, Pascal Mireault, C. Skinner   +4 more
semanticscholar   +1 more source

Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).

Drug Testing and Analysis, 2017
A. Steuer, Elena Williner, Sandra N. Staeheli, T. Kraemer   +3 more
semanticscholar   +1 more source

Drugs by Design

Scientific American, 1993
C E, Bugg, W M, Carson, J A, Montgomery
openaire   +2 more sources

5‐MeO‐DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis

Acta Anaesthesiologica Scandinavica, 2016
A. Kalasho, S. Vibe Nielsen
semanticscholar   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino, Roberto Carmagnani Pestana, Shanu Modi   +2 more
exaly  

GC-MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case.

Forensic Science International, 2016
Marcel Grapp, C. Sauer, C. Vidal, D. Müller   +3 more
semanticscholar   +1 more source

Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).

Journal of Mass Spectrometry, 2015
M. Paul, S. Bleicher, Susanne Guber, J. Ippisch, A. Polettini, Wolfgang Schultis   +5 more
semanticscholar   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Drug Design: Designer Drugs

2010
Gerd Folkers, Elvan Kut, Martin Boyer
openaire   +1 more source